GL Pharm Tech Corp. 204840.KQ Stock
GL Pharm Tech Corp. Price Chart
GL Pharm Tech Corp. 204840.KQ Financial and Trading Overview
| GL Pharm Tech Corp. stock price | 1194 KRW |
| Previous Close | 780 KRW |
| Open | 774 KRW |
| Bid | 790 KRW x 0 |
| Ask | 794 KRW x 0 |
| Day's Range | 774 - 805 KRW |
| 52 Week Range | 655 - 1164 KRW |
| Volume | 89K KRW |
| Avg. Volume | 808.68K KRW |
| Market Cap | 28.66B KRW |
| Beta (5Y Monthly) | 1.194953 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
204840.KQ Valuation Measures
| Enterprise Value | 57.91B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.9814181 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 4.003 |
| Enterprise Value/EBITDA | -51.569 |
Trading Information
GL Pharm Tech Corp. Stock Price History
| Beta (5Y Monthly) | 1.194953 |
| 52-Week Change | -17.19% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1164 KRW |
| 52 Week Low | 655 KRW |
| 50-Day Moving Average | 813.74 KRW |
| 200-Day Moving Average | 792.55 KRW |
204840.KQ Share Statistics
| Avg. Volume (3 month) | 808.68K KRW |
| Avg. Daily Volume (10-Days) | 146.37K KRW |
| Shares Outstanding | 35.78M |
| Float | 44.12M |
| Short Ratio | N/A |
| % Held by Insiders | 28.94% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -11.071% |
| Operating Margin (ttm) | -22.19% |
| Gross Margin | 31.61% |
| EBITDA Margin | -7.76% |
Management Effectiveness
| Return on Assets (ttm) | -5.68% |
| Return on Equity (ttm) | -13.35% |
Income Statement
| Revenue (ttm) | 14.47B KRW |
| Revenue Per Share (ttm) | 237.51 KRW |
| Quarterly Revenue Growth (yoy) | 87.50% |
| Gross Profit (ttm) | 3.75B KRW |
| EBITDA | -1122871424 KRW |
| Net Income Avi to Common (ttm) | -1601659392 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.54B KRW |
| Total Cash Per Share (mrq) | 89.28 KRW |
| Total Debt (mrq) | 14.59B KRW |
| Total Debt/Equity (mrq) | 91.54 KRW |
| Current Ratio (mrq) | 1.615 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2972254208 KRW |
| Levered Free Cash Flow (ttm) | -8139045376 KRW |
Profile of GL Pharm Tech Corp.
| Country | South Korea |
| State | N/A |
| City | Seongnam-si |
| Address | 714, Jungang Indussia 5 |
| ZIP | N/A |
| Phone | 82 3 1739 5220 |
| Website | https://www.glpt.co.kr |
| Industry | |
| Sector(s) | |
| Full Time Employees | 22 |
GL Pharm Tech Corp. provides generic drugs and incrementally modified drug (IMD) formulation technology to pharmaceutical companies in South Korea. The company offers IMD for gastritis, antidepressant, anorectic, and antibiotic indications. It also provides generic drugs for cardiovascular, urology, pain, anti-infection, gastric disease, diabetes, central nervous system disease, respiratory disease, transplantation, and other areas. In addition, the company engages in developing new molecule entity pipeline products for dry eye disease. Further, it provides Cabalin CR extended-release tablet and Jample Ibufen syrup for the nervous system and sensory organs; Gisoren tablets for individual organs, digestive system, and peptic ulcer drugs; and Genstring Troki for treating individual organs and digestive system, as well as oral use. GL Pharm Tech Corp. was founded in 2002 and is headquartered in Seongnam, South Korea.
Q&A For GL Pharm Tech Corp. Stock
What is a current 204840.KQ stock price?
GL Pharm Tech Corp. 204840.KQ stock price today per share is 1194 KRW.
How to purchase GL Pharm Tech Corp. stock?
You can buy 204840.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GL Pharm Tech Corp.?
The stock symbol or ticker of GL Pharm Tech Corp. is 204840.KQ.
How many shares does GL Pharm Tech Corp. have in circulation?
The max supply of GL Pharm Tech Corp. shares is 35.78M.
What is GL Pharm Tech Corp. Price to Earnings Ratio (PE Ratio)?
GL Pharm Tech Corp. PE Ratio is now.
What was GL Pharm Tech Corp. earnings per share over the trailing 12 months (TTM)?
GL Pharm Tech Corp. EPS is 0 KRW over the trailing 12 months.
GL Pharm Tech Corp. 204840.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq Composite Index KQ11 | 848.53 KRW 0.64 USD |
-1.39
|
546.42K KRW 412 USD | 842.84 KRW 0.64 USD | 851.22 KRW 0.64 USD | — - | 546.42K KRW 412 USD |
| Kosdaq Small Index KQSM | 2737.08 KRW 2.07 USD |
-1.29
|
354.59K KRW 268 USD | 2724.25 KRW 2.06 USD | 2751.73 KRW 2.08 USD | — - | 354.59K KRW 268 USD |
| Kosdaq Other Services Index KQ16 | 3522.26 KRW 2.66 USD |
-2.5
|
15.31K KRW 12 USD | 3508.16 KRW 2.65 USD | 3576.45 KRW 2.7 USD | — - | 15.31K KRW 12 USD |
- {{ link.label }} {{link}}